For healthcare, pharma and life sciences
Content marketing for healthcare, pharma and life sciences.
Your people already write more than almost anyone. The trouble is where: in journals, behind paywalls, for other researchers. Findwell takes that same expertise and puts it where a procurement lead, a clinician or an investor is actually looking.
- A hub, and the team that fills itSoftware on your domain with a page per specialist, prepared by us for your own review
- Specialists who get foundRanking on Google, quoted in the trade and science press, named in AI answers
- From £1,000Per specialist a month, six month minimum, no setup fee
What Findwell is
A content platform, and the agency that translates your experts.
Two things that are usually bought separately, and that only work together. Here is the whole proposition in one line.
The work
An agency that translates the science
We interview your clinicians and scientists, capture their voice, prepare it for medical and regulatory review, and pitch it out.
The place
A platform of your own to hold it
A hub on your subdomain with a page per specialist, structured so search and AI can read it.
Findwell
The platform, with the people who feed it
Up in about two weeks, with only an hour a month from each expert needed.
What it is
A page for every specialist, in language the buyer reads.
On a subdomain of your own site. What they work on, what the evidence actually shows and what it means in practice, structured so search engines and answer engines can attribute it to a named expert.
Step through what the page does
We get the expert view and we make it accessible without losing its qualifications. It goes through your medical and regulatory review before anything runs.
And how it works
Plain English without losing the qualification that makes the claim true. Every statement referenced, so a reviewer is checking sources rather than rewriting sentences.
Scope agreed with medical and regulatory before a word is written, and nothing published that has not been signed. We work to your review cycle rather than asking it to move.
Where we secure coverage for health and life sciences clients
What you get
Everything a specialist needs, made for them.
You get all this out of a single conversation with us. We make it, we take it through review, we place it, and every piece lands back on their own page.
Shapes everything below
Published, then on the hub
Lives on the hub
Posted, then links to the hub
Sent, then kept on the hub
Cut, then hosted on the hub
See what your specialists would rank for.
A thirty-minute walkthrough on your own firm. We will show you where your specialists sit today, and what the first quarter would produce.
How it works
One hour a month. We do the rest.
The whole commitment from each specialist, in one picture.
That is the whole ask. You talk, your reviewers sign, and everything in between is ours.
You talk
Recorded, with an editor who knows the field well enough to push back, and to notice when a qualification is doing real work.
Review signs
We draft in their voice, reference every claim, and submit it to medical and regulatory review. Specialists review and approve rather than write.
We do the rest
Published on your hub, pitched to the health and science desks, then cut for LinkedIn, the briefing and video.
A worked example, not a client
What a year looks like for one specialist.
The plan we would put in front of a regulatory lead in week one, quarter by quarter. No firm has to imagine what the retainer produces.
The specialist
Nine approvals and forty citations, and nothing a customer could read without a subscription.
The niche
When software becomes a regulated medical deviceNarrow enough that one person can own it, broad enough that founders, clinical safety officers and procurement teams are all searching it at once.
Why that one
2,100searches a month across the cluster, and almost no expert-level pages answering any of it
Pick the nicheStep 1 of 5
Once, before anything is published
Content strategy
Agreed with Aisha and with BD before a word is written, so there are no surprises on scope down the line- What specialist question Aisha can hone in on. Picking a narrow question about software becoming a device is winnable, regulatory affairs are not
- The questions worth answering, ranked by what buyers search rather than by what we publish on
- What can be said non-promotionally, agreed with medical and regulatory on day one
Biography and specialist page
Not the publication list and not the conference bio, both of which are written for other researchers- The areas Aisha can talk about, and the programmes still confidential
- What Aisha is known for, in the words a procurement lead would use
- Structured so search and answer engines can attribute it to a named expert with a real record
Social refresh
Distributors and clinicians check this straight away, and it currently lists conferences from 2019- Headline and about section rewritten around the niche rather than the firm
- Featured section pointing back at the hub
- Banner and profile consistent with the specialist page
Live in a couple of weeks, with nothing required from your web department. Before anyone has to approve a word of content, we agree with Aisha on what she is claiming to be an expert in.
First on the recordStep 2 of 5
Every month
3 insight extractions, one a month
One forty-minute recorded conversation, properly conducted by an editor who can challenge assumptions. Everything below is created from it.- The argument Aisha makes to every founder who has already shipped
- How development has been affected by a guidance change
- The claim Aisha keeps seeing that makes a product regulated
3 newsletters, one a month
Drawn from Aisha's interviews, shared with her network, and captured on the hub so every piece keeps building the wider profile- When your software becomes a medical device
- The three claims that turn wellness into a regulated product
- Classification, and where people consistently get it wrong
1 media piece: an op-ed
The first piece is built around an argument Aisha can own, giving it its own moment rather than chasing the latest story- “Most digital health companies find out too late”, in Med-Tech Innovation
5 video clips filmed
The expertise is captured once, and a year's worth of video is delivered at the same time- The three claims that make you a regulated product
- What classification actually means, in plain English
- Wellness or medical device, and how to tell
- Can you self-certify, and what to check first
- What happens when you get classification wrong
LinkedIn, as it comes
No content treadmill that no one believes in. Posts follow each piece and whenever there is a natural reason for Aisha to speak on the news- A post for every piece we publish
- A reaction on the days the MHRA publishes new guidance
- Comment on a guidance change while people are still reading it
Indexed within the month. What usually happens first is that your own sales team starts sending it. A clear regulatory explainer answers the question that stalls almost every first call. Rankings will follow.
Build the body of workStep 3 of 5
Every month
3 insight extractions, one a month
The conversation keeps moving as the market changes: new matters, new rules and Aisha's latest point of view- What the new guidance has done to timelines a year on
- Where submissions are stalling, and what that looks like early
- The AI question Aisha gets asked most
3 newsletters, one a month
Each republished on the hub. At this point, the cluster starts working together rather than sitting as isolated articles- Clinical evaluation for software, without a trial
- What the MHRA actually asks to see
- Post-market surveillance nobody budgets for
1 media piece: an interview
Using a live story as a hook, Aisha becomes the name in front of the desk when it needs an expert. A harder placement to earn than an op-ed- Interview with Digital Health on what the guidance has done to approval timelines
Video running
One conversation in quarter one, broken into the questions clients actually ask and released fortnightly- One clip a fortnight, on the hub and on LinkedIn
- Each one answering one question and nothing else
- Subtitled, because most of it is watched on mute
LinkedIn, as it comes
Each piece of content gets its own post, with further commentary from Aisha whenever the news warrants it- A post for every piece we publish
- Reaction on the days the numbers or a judgment land
- The occasional short answer to a question Aisha keeps being asked
Before clinicians and directors start enquiring, distributors and procurement become interested. They are the people who have to be satisfied before anybody else is even asked.
Called before the story runsStep 4 of 5
Every month
3 insight extractions, one a month
One of the usual insight calls doubles as a filming session, so nothing more goes in Aisha's diary- What a notified body can and cannot ask for
- The timeline conversation boards have too late
- What the approval data actually shows, under the headline
3 newsletters, one a month
Each edition goes live on the hub as well. Nine newsletters becomes a substantial body of coverage- AI as a medical device, and what actually changes
- What a notified body actually reviews
- Reading the MHRA guidance properly
1 media piece: broadcast
When the news moves quickly, journalists call the experts they already know. The first two quarters are about becoming one of those names- Radio or podcast comment on the health technology story running that week
5 more clips filmed
The second sitting, six months on, to carry the rest of the year- AI features, and what they do to your risk class
- Notified body review, in plain English
- The approval data, and what it really shows
- Post-market surveillance on a realistic budget
- Talking to your board about approval timelines
LinkedIn, as it comes
At this point, the same thinking is reaching journalists as often as it reaches clients- A post for every piece we publish
- A same-day reaction when the MHRA updates its guidance
- The clips, one at a time, as they come out
The calls start coming in, rather than us pitching out. When founders start to ask their assistants whether their product is regulated, Aisha's name is brought up.
Own directors' dutiesStep 5 of 5
Every month
3 insight extractions, one a month
The final cycle is where we identify the next question Aisha should own- What changed this year in UK approval
- Where Aisha thinks the bottlenecks land next year
- The question Aisha wants to be known for in year two
3 newsletters, one a month
The year’s content feeds into a one-page flagship guide that has the strongest opportunity to rank- Software as a medical device, the annual guide
- What changed this year in UK approval, and what did not
- Where approvals bottleneck next year, class by class
1 media piece: a year-ahead op-ed
Forecast season arrives, and Aisha has moved from being pitched as an expert to being recognised as one- “The health products that will not reach patients next year”, pitched to a national
Video running
The quarter three sitting creates the next series, continuing the fortnightly cadence- One clip a fortnight, on the hub and on LinkedIn
- The annual guide cut down into a two-minute explainer
LinkedIn, as it comes
Each piece creates another reason to post, but the year-ahead piece becomes the one that carries the most authority- A post for every piece we publish
- The year-ahead argument, in Aisha’s own words, ahead of the op-ed running
The point where the cluster answers the whole question is where the quality of inbound changes. It starts generating procurement and partnership conversations rather than just traffic, from buyers who arrive already understanding the argument
What that adds up to
12 hours
Of the specialist’s time across the year. Twelve insight extractions, one a month, and a read of the drafts. The filming happens on two of those same days, so it costs nothing extra.
Across the sector
The model is the same. What we publish is not.
A regulatory lead at a device company and a medical affairs lead at a pharma company may sit in the same sector, but they are found by entirely different audiences.
Device buyers are searching the regulation, not the product
Regulatory and clinical leads at device companies use our support with classification explainers, evidence guidance, approval commentary and the notes procurement teams keep on file.
Nobody buys a device on a brochure any more. A trust or a distributor is trying to work out whether it will clear, whether the evidence holds and who has done this before. Your specialist is the one who has already explained it in public.
The team behind it
You are hiring people, not software.
Findwell is a product of Profile, an award-winning thought leadership and PR agency. So is the team.
“This is the only sector I work in where the expertise is already written down. It is in journals, behind paywalls, in a format built for reviewers rather than readers, and the person who needs it is a procurement lead with twenty minutes. Nobody has to become a writer here. Somebody just has to sit with the expert and ask what it means, then publish the answer where the question is actually being asked.”
Jordan GreenawayFounder, Profile
Questions
What firms ask before they start.
+How much does content marketing for healthcare and life sciences cost?
+Our people already publish in journals. Why is this different?
+How does this work with the ABPI Code?
+Can we talk about a product that is not approved yet?
+Is this SEO, AEO, GEO, PR or thought leadership?
+Who writes it, and how much specialist time does it take?
+How long before our specialists rank for these questions?
+What happens to the content if a specialist leaves?
+Can we start with a couple of people rather than the whole company?
+Why not just hire someone to do this in-house?
See what your specialists would rank for.
A thirty-minute walkthrough, on your own firm, of where your specialists sit today and what it would take to move them.